RLIM, also known as RNF12, is an X-linked E3 ubiquitin ligase acting as a negative regulator of LIM-domain containing transcription factors and participates in X-chromosome inactivation (XCI) in mice. We report the genetic and clinical findings of 84 individuals from nine unrelated families, eight of whom who have pathogenic variants in RLIM (RING finger LIM domain-interacting protein). A total of 40 affected males have X-linked intellectual disability (XLID) and variable behavioral anomalies with or without congenital malformations. In contrast, 44 heterozygous female carriers have normal cognition and behavior, but eight showed mild physical features. All RLIM variants identified are missense changes cosegregating with the phenotype and predicted to affect protein function. Eight of the nine altered amino acids are conserved and lie either within a domain essential for binding interacting proteins or in the C-terminal RING finger catalytic domain. In vitro experiments revealed that these amino acid changes in the RLIM RING finger impaired RLIM ubiquitin ligase activity.
Introduction
The X-linked RLIM gene, also known as RNF12, encodes a widely expressed RING (Really Interesting New Gene) domain-containing zinc-finger protein with diverse cellular functions. This protein serves as a cofactor promoting or inhibiting transcription factor activity and acts as an E3 ubiquitin ligase ubiquitinating its target proteins for subsequent degradation by the proteasome [1, 2] . In humans, rare nucleotide changes in RLIM (MIM 300379) were identified recently in four families with X-linked intellectual disability (XLID) [3, 4] , with clinical information reported for one family [4] and for a second family published in Spanish [5] . While our current understanding of the functions of human RLIM is sparse, its mouse ortholog (Rlim/Rnf12) has been studied in vitro [6, 7] and in vivo [6, 8] . RLIM binds to LIM-homeodomain (LIM-HD) transcription factors and their cofactors CLIM (also known as NLI, Ldb, and Chip). It was identified as a negative regulator of LIM-HD transcription factors, acting either as a co-regulator via the recruitment of the Sin3A/histone deacetylase corepressor complex, or by targeting the cofactors for proteasomal degradation [8, 9] . Subsequent studies showed that in the mouse and Xenopus RLIM/Rlim is an important protein involved in early embryogenesis [10] [11] [12] , e.g., lung, brain, and neural tube development [13] . In addition, mouse RLIM activates X-chromosome inactivation (XCI) [14] [15] [16] . In vitro studies in embryonic stem cells indicated that RLIM targets the XCI inhibitor REX1 for proteasomal degradation via polyubiquitination [2] , and that at least one functional copy of Rlim is required to reduce REX1 levels sufficiently for initiation of XCI [17] . Furthermore, in mammalian cells RLIM is involved in telomere length homeostasis, promoting the ubiquitination of TRF1 [18] . RLIM plays a role in cell proliferation through the targeted degradation of stathmin [19] ; upregulation of the p53 pathway through ubiquitination of MDM2 and proteasomal dependent degradation [20] and inhibiting the transcriptional activity of c-Myc through polyubiquitination of the c-Myc protein [6] . RLIM may thus act as a tumor suppressor on p53 and c-Myc. The range of RLIM functions extends further, primarily through its role in the ubiquitination of diverse substrates. RLIM is a positive regulator in the TGF-beta family signaling pathway. It affects cell migration by ubiquitinating the negative regulator Smad7 [11] and through its direct binding to the E3 ubiquitin-protein ligase SMURF2 [21] . Furthermore, RLIM affects expression of estrogen responsive genes through ubiquitination [22] and phosphorylation [23] of estrogen receptor alpha [6, 12, 22, 23] and hereby regulates its biological activity together with its cofactor CLIM in primary breast cancer tumor cells [22] . RLIM is a critical survival factor for mammary gland milk-producing alveolar cells [22] .
Here we describe the recognizable and behavioral clinical phenotype of nine RLIM-affected families, including the evolving phenotype in affected males. All heterozygous carrier females have normal cognition and behavior, but a few have physical features, including mainly minor skeletal abnormalities. In vitro functional assays showed that patient-specific single amino acid substitutions located in the C-terminal RING-H2 zinc finger domain of RLIM led to decreased ubiquitin ligase activity. In vivo functional studies in zebrafish revealed that lack of rlim caused microcephaly and that none of the patient-specfic RLIM missense variants rescued this phenotype. Taken together, our genetic and functional data suggest that these RLIM missense variants are most likely causative for the clinical phenotype in the respective families.
Materials and methods

General workup
For all families, except Family E, at least the index patient was tested initially for karyotype, FMR1 CGG repeat expansion and by microarray copy number variant analysis; and the results were normal except for one affected male (C.IV:2) who carried an 8q21.3 (1.1 Mb) duplication of unknown clinical significance. Families D (D072), F (MRX61/T11), and H (AU31) (Fig. 1) were part of our previous study on 405 families with unresolved XLID. RLIM variants identified in these families were reported earlier with limited clinical information [3, 5] . Family B, included in the clinical assessment and functional assays reported here, has been published before [4] . Families C, D, and F have been revisited and/or were reevaluated clinically. All families were evaluated by a clinical geneticist and/or pediatrician (for more clinical details see Supplementary text). The study was approved by the review boards of the participating institutions. Written informed consent of the included individuals was obtained from their parents or legal guardians.
Next-generation sequencing
Genomic DNA was isolated from peripheral blood and/or skin fibroblasts according to standard procedures. Nextgeneration sequencing was performed at different centers according to standard procedures. Trio based whole exome sequencing (WES) was performed in Family A on a clinical basis as described in Retterer et al. [24] . Index patients from Families C, D, F, and H were investigated by X-chromosome exome sequencing. Reads were mapped to the human reference genome hg18 via Razers [25] called with the following options: -mcl 25 -pa -m 1 -dr 0 -i 93 -s 110101111001100010111 -t 4 -lm -id. The data were processed as described in Hu et al. [3] , including a split-read mapping approach (SplazerS [26] ) and analysis of read depth to comprehensively call insertions and deletions. All detected sequence variants were lifted-over to genome version hg19 and functionally prioritized [3] . For Family E, whole genome sequencing (WGS) libraries were constructed using the Illumina TruSeq DNA PCR-Free Library Preparation Kit. Paired-end 150 bp reads were generated on an Illumina HiSeq 4000 to a minimum depth of 30× coverage. FASTQ files were generated and secondary data analysis was performed using Churchill, a pipeline that implements a best practices workflow for variant discovery and genotyping [27] . SNPeff, ANNOVAR, and custom in-house scripts were used to annotate the variant call set with mutation and gene information, protein functional predictions, and population allele frequencies. These annotations were used to identify rare (MAF <1% in ExAC) likely deleterious variants consistent with recessive inheritance (homozygous, compound heterozygous or X-linked hemizygous variants). No high confidence de novo coding variants were detected. The resulting 20 variants affecting 15 genes (four homozygous recessive, eight compound heterozygous, and three X-linked hemizygous) were reviewed by the Rare Disease Genomics Board (an internal case review committee at Nationwide Children's Hospital, USA). For Family G, WES was performed for the two affected male cousins (G.IV:2 and G. IV:5) on a Hiseq2000. One hundred base pair paired-end reads were aligned to the reference genome using Burrows-Wheeler aligner. The quality metrics for mapping were calculated with Picard. Genome Analysis Toolkit framework was used for local realignment. Variants were annotated with Annovar. Total mapped reads number varied from 80, 721, 383 to 121, 928, 698 for the two samples with a minimum mean coverage at each target of 76 reads. On average, 93.8% of the bases were covered by at least 10 reads and 81% of the bases reached at least 30× sequence coverage. Variants were filtered based on their frequency and protein effect with exclusion of variants with MAF ≥0.01 in public databases for synonymous variants. Exome sequencing revealed shared rare variants in RAB40A and RLIM. The variant in RAB40A (NM_080879: c.A485G: p.(Asn162Ser)) has a minor allele frequency of 0.0014 in gnomAD (300/ 200128) and is present in 108 hemizygous and one homozygous individuals which makes it likely a benign variant. For family I, WGS was performed in the proband (III:10) and the parents (II:10, II:11), one aunt (II:1), and one uncle (II:2) underwent WES. The sequencing library for WGS was prepared using the Nextera DNA Library Preparation Kit (Illumina, San Diego) and sequenced on a HiSeq2500 (Illumina, San Diego) to an average depth of 17 times. All WES experiments were run on a GAIIx (Illumina, San Diego) after enrichment using the SeqCap EZ v2 enrichment kit (Roche, Pleasanton). The average mean depth of all WES was 91 times and 92% of all targets were covered with at least 10 times. On average 83, 723, 779 reads were generated per WES and 477, 781, 686 reads for WGS. Reads of all experiments were mapped using BWA (v.0.7.15), variants were called with freebayes (v.0.9.20 and 1.1.0) and annotated with SnpEff/SnpSift (v.4.1c and 4.3i). In-house scripts were used for QC and further functional annotation. All variants were filtered according the following rules: (1) keep only variants on the X-chromosome since the family history suggested X-linked inheritance, (2) only variants hemizygous in proband, heterozygous in obligate female carriers but not present in the proband's father were kept, (3) all not coding/ splicing variants were removed, and finally (4) all variants with an allele fraction of >1% in ExAC were removed. With this strategy four variants remained and were further analyzed by segregation analysis in other affected individuals (brother (III:9) and two cousins (III:2, III:4)).
Linkage and segregation analysis
For families D, F, and G, linkage analysis was performed as described [5, 28, 29] . For all families, segregation analysis was performed with primer pairs flanking the variants identified in the families. Primer sequences are available upon request.
X-inactivation studies
For X-inactivation studies, DNA extracted from blood lymphocytes and skin fibroblasts was analyzed for the methylation sensitive site of FMR1 exon 1 [30] and/or the CAG repeat of the androgen receptor gene [31] . For more details see Supplementary Materials and Methods.
Functional studies of RLIM variants in cells
The coding sequences of human RLIM and REX1 were amplified from human cDNA and cloned into the TOPO Blunt II vector (Invitrogen). RLIM mutation constructs were generated by PCR site-directed mutagenesis. For mammalian expression, the wild type (WT) and the mutant RLIM coding sequences were subcloned into pCAG-FLAG (gift from D. van den Berg), a CAG-driven expression vector containing a FLAG-tag; REX1 was subcloned into pCAG-FLAG-V5 vector.
HEK293 cells were cultured under standard conditions with 50% DMEM/50% Ham's F10, supplemented with 15% heat inactivated fetal calf serum, 100 U/ml penicillin, 100 mg/ ml streptomycin, nonessential amino acids. For the ubiquitination assay, cells grown in 10 cm dishes were transiently transfected with polyethylenimine (Polysciences Inc.) for 48 h Results were not interpretable for F.II:1, F.III:1, F.III:3; random X-inactivation profiles in B.II:7, B.III:2, F. II:3, F.IV:2 and F.IV:5 who are all noncarriers. POI premature ovarian insufficiency. MCA lethal: in most cases a lethal type of congenital diaphragmatic hernia with associated lung hypoplasia was present with mild growth retardation of prenatal onset, facial dysmorphism, (relative) microcephaly and hypogenitalism including micropenis with absent or small testes, cryptorchidism and/or hypospadias with limb anomalies, e.g., short terminal phalanges, preaxial polydactyly, hypoplastic absent or short nails (See also Supplementary Figures 2 and 4 ). with 3 μg WT or mutant RLIM expression vectors, in the absence or presence of 3 μg V5-tagged REX1 expression vector. Where indicated, cells were treated with 15 µM proteasome inhibitor MG132 (Sigma) for 3 h before harvesting.
Cells were collected by scraping on ice-cold PBS plus protease inhibitor (Roche). To isolate nuclear extracts, cells were incubated with 400 µl buffer containing 10 mM Hepes, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, protease inhibitor, and 15 µM MG132 for 10 min on ice. After vortexing briefly, nuclei were resuspended in buffer containing 20 mM Hepes, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, protease inhibitor and 15 µM MG132 and incubated for 20 min on ice. After centrifugation, the supernatant was used as nuclear extract. For immunoblotting 20 µg of nuclear extract was used and detected with antibodies against RLIM (B01P, Abnova), V5 (Invitrogen), and β-ACTIN (Sigma) was used as a loading control. To recover V5-tagged REX1 15 μl of V5 antibody-agarose beads (Sigma) were added to nuclear extracts and the mixture was incubated for 2 h at 4°C. The beads were washed with buffer containing 20 mM Hepes, 10% glycerol, 150 mM KCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.02% NP40, 0.5 mM DTT, protease inhibitors, and 15 µm MG132. Bound proteins were eluted with sample buffer and visualized by immunoblotting. Co-immunoprecipitated RLIM was detected with RLIM antibody, and poly-ubiquitinated REX1 with a V5 antibody.
Knockdown of rlim in zebrafish, rescue experiments, staining, and embryo manipulation
Zebrafish embryos were raised as described [32] . All animal experiments were carried out with the approval of the Institutional Animal Care and Use Committee. A spliceblocking morpholino (sb-MO) against the third exon-intron junction of rlim: (5′-CTGTCGCTGGGAATGACAA-GAAATT-3′) was designed and purchased from Gene Tools. For RNA rescue experiments, human WT RLIM DNA (NM_183353.1) was obtained from Open Biosystems (Clone ID: 3834870) and cloned into a pCS2+ vector. The seven patient-specific missense changes, p.(Pro77Leu), p.(Tyr356Cys), p.(Arg365Cys), p.(Arg387Cys), p.(Pro587Arg), p.(Arg599Cys), p.(Arg611Cys), and the polymorphic p.(Asn178Thr) change which served as a control were introduced into the full-length RLIM construct by site-directed mutagenesis. In vitro transcription of WT and mutant constructs was performed using the SP6 Message Machine kit (Ambion). The rlim sb-MO (2 ng) and RLIM WT or mutant RNA (100 pg) were injected into zebrafish embryos at one-to two-cell stage. Morpholino efficiency was determined by RT-PCR. Total RNA was extracted from 2 day-old embryos using TRIzol® Reagent (Life Technologies). First-strand cDNA was synthesized using Superscript® III with oligo(dT) primer and PCR amplification was carried out using zebrafish rlim primers (Forward, 5′-GAACCGACTTAGGCAGGTCA-3′ and Reverse, 5′-AAGGTTGATCGGTGAACGAC-3′). Injected embryos were scored at 5 days post-fertilization (dpf) for head area measurement. For staining, embryos were fixed in 4% PFA overnight. After gradual rehydration, embryos were treated with a bleach solution (1% H 2 O 2 , 0.1% KOH in 1% PBS) and stained with Alcian Blue solution (1% HCl, 70% EtOH, 1% Alcian blue). Embryos were cleaned with acidic ethanol (5% HCl, 70% EtOH) and imaged in 100% glycerol. All images were acquired on a Nikon macroscope. T-test was performed to determine significance between the tested conditions. Investigator was blinded when assessing the outcome and no method of randomization was used.
Generation and validation of rlim guide RNA (gRNA)
A gRNA was designed to target exon 1 of rlim as described [33] . Oligonucleotides (Forward, 5′-TAGGTCAGGA-TAATGCAGATCA-3′ and Reverse, 5′-AAACTGATCTG-CATTATCCTGA-3′) annealed and cloned into pT7Cas9sgRNA vector (Addgene) by BsmBI. Template DNA was linearized by BamHI and purified by phenol/chloroform extraction. Then the gRNA was in vitro-transcribed with MEGAshortscript T7 kit (Invitrogen). Subsequently, gRNA (100 pg) and Cas9 (200 pg) protein (PNA bio, CP01) were directly injected into one-cell stage embryos. For the efficiency of gRNA, genomic DNA from each embryo (F0) was extracted by proteinase K digestion (Life technologies, AM2548). By using a primer set (Forward, 5′-TATTTTTCTCTCGATGCGTGTG-3′ and Reverse, 5′-TGAAAATTGTTTTTACCAGGGG-3′) flanking the targeted genomic editing site, the genomic region was amplified, followed by denaturing and slow reannealing to facilitate heteroduplex formation (denaturing step: 5 min, followed by reannealing step: cooling to 85°C at −2°C/s and additional to 25°C at −0.1°C/s). The reannealed PCR amplicon was subjected to digestion by T7 endonuclease I (New England Biolabs, M0302L) at 37°C for 1 h, and was resolved on 1.5% agarose gel. For the confirmation of genome editing at the rlim locus, PCR fragments were cloned into the pCR4/TOPO TA cloning vector (Life technologies, 450030), and each clone was Sanger sequenced; the percentage of mosaicism was determined and estimated at~75% in the F0 population.
Results
RLIM-affected males have a recognizable and behavioral clinical phenotype
Pedigrees of the families studied and their RLIM variants are shown in Fig. 1 . Affected males and carrier females were assessed clinically using a scoring list. Clinical symptoms present in at least five unrelated affected males are summarized in Table 1 with more details provided in the Supplementary text and in Supplementary Table 2 . Clinical information on affected carrier females is presented in Supplementary Table 3 . For the affected males, clinical data were obtained for 40 subjects, including three fetuses ( Table 2 ).
Global developmental motor and speech delay, as well as ID, were reported for all 29 surviving affected males (29/40 = 73%). Cognitive dysfunction varied from borderline to severe ID. Speech delay and expressive language were of concern. In childhood, the boys were rather quiet and shy (12/12), presented with autistic-like features (15/17), and had an amiable social personality (13/13). In adolescence and adulthood significant behavioral problems were present. These included (hetero-) aggressive behavior including verbal aggressiveness (11/11), temper tantrums or outbursts of anger (12/12), anxiety (14/15), self-injurious behavior, e.g., hand biting (5/10), repetitive autistic or obsessivecompulsive like behaviors (15/17) and hyperactivity (5/6). In the adult-affected males (20/40), anxiety (14/15), abnormal behavior (8/11), and/or being unhappy or having depressed mood (8/11) with disturbed sleep (6/11) was reported. One affected male (C.IV:2) had a diagnosis of schizophrenia. Seizures were reported in three unrelated males (A.II:2, D. V:1, F.III:8) varying from infrequent seizures to well controlled with medication (e.g., Depakine). Seizure types included mainly absences (D.V:1, F.III:8), but a complex 7) ). Progressive tetraplegia with Alzheimer type dementia was reported in one male (D.II:1). Brain abnormalities on neuroimaging/neuropathology were noted in three males across two families (3/8 tested individuals). However, the majority of males did not have neuroimaging and brain MRI was normal in 5/8 investigated males. Atypical white matter abnormalities were noted in childhood in three boys (Fig. 1 , A.II:2, D.V:1, D.IV:4). One had periventricular leukomalacia, thin corpus callosum and pineal gland cyst (A.II:2); one had atypical white matter hypomyelinisation and pituitary gland hypoplasia (D.V:1) (Supplementary Table 2 and Supplementary Figure 5 ); and one had a spontaneous intracranial hemorrhage at age 28 years (D.IV:4), from which he recovered well. Affected males from two families (Families F (MRX61) and H) had been considered previously as non-dysmorphic. However, following reassessment and comparison of their clinical features and photographs taken at various ages with affected males from unrelated families (Fig. 2) , it became obvious that they had an evolving and recognizable clinical and behavioral phenotype.
Moreover, diseased newborns and boys with pathogenic RLIM variants, or a variant of unknown significance in the case of Family A with p.(Pro77Leu), had (mild) prenatal growth retardation/postnatal short stature (birth length <3rd percentile) (11/14) and dysmorphic features (17/40) . Common facial dysmorphic features in childhood and adulthood (Fig. 2, upper (17/23) , and widely spaced teeth (6/10). There were significant feeding difficulties during infancy, mainly as a result of velopharyngeal insufficiency and swallowing difficulties (8/8) . A few affected males presented with a small oropharynx with high narrow palate (6/6) and one male (D.III:8) had a bifid uvula.
In adulthood (Fig. 2, lower panel) growth parameters were generally within the normal range (9/14). The faces became narrower (11/15) and longer (12/15) with a high narrow nasal bridge (15/15) and a prominent beaked nose in several males (5/15 ). Most were normocephalic (8/13) and had hypotelorism (13/14) . Ears were mostly well-shaped (22/25) and hearing and vision were normal (20/20) . Affected males had a lean body habitus (17/18). Adult males had truncal/central obesity (7/13) .
Urogenital abnormalities included micropenis (9/10), cryptorchidism (8/10), small or absent testis (9/11 by ultrasound investigation), and hypospadias (4/10). In one child (G.IV:5) and one deceased newborn (I.III:2) cysts of the renal collection ducts were present. Abdominal features reported in a few males included omphalocele (2/23), liver cysts (E.IV:1 multiple liver cysts in left lobe and G.VI:2 multiple liver cysts with ductal plate malformation), polysplenia (I.III:2), and malrotation of bowel (I.III:9).
Hands showed short distal phalanges with broad stubby thumbs (14/16), camptodactyly (3/19), syndactyly (2/20), and nail hypoplasia or absent nails (5/17) ( Supplementary  Figures 2 and 4 ). Feet showed pes planus (6/8), preaxial polydactyly (3/20) , and/or with (partial) cutaneous syndactyly (3/13) ( Supplementary Figures 2 and 4) .
Four affected males had congenital heart defects (CHD) (4/23), two with aortic stenosis (D.III:11, D.V:1), one with aortic isthmus stenosis with persistent foramen ovale and an atrial septal with persistent left upper vena cava, isolated separation of vertebral artery) (I.III:10) and one with Tetralogy of Fallot (D.IV:4).
Cognition, behavior and facial phenotype were normal in the 44 heterozygous RLIM female carriers assessed (Supplementary Figure 3 and Supplementary Table 3 ). However, several female carriers were noted to have clinical or biochemical evidence of premature ovarian insufficiency (POI) (7/8). Nevertheless, carrier females of Family C conceived spontaneously, despite a paradoxically low AMH level. Clinical reevaluation of Family D revealed that female carriers had relatively short stature compared to their noncarrier sisters ( Supplementary Figure 3) , somewhat broad stubby thumbs with short distal phalanges (4/4 compared to Heterozygous RLIM female carriers have highly skewed XCI XCI studies were performed on blood leukocytes or skin fibroblasts of fourteen heterozygous female carriers from five families (B [4] , C, F, G, and H) and five noncarrier female relatives. While in thirteen female carriers XCI was (highly) skewed (90-100%), one female carrier showed less skewing (87%, F.IV:8). In contrast, five noncarrier female relatives had random XCI (between 61 and 81%, B.II:7, B. III:2, F.II:3, F.IV:2, F.IV:5) ( Fig. 1 and data not shown) . We investigated whether the RLIM variant in heterozygous female carriers was located on the inactive X-chromosome by performing more detailed studies on skin-derived fibroblast DNA and RNA from two females (C.IV:5 and C. IV:7). Methylation based X-chromosome inactivation ratio's (XIR) analysis confirmed skewed XCI in their fibroblasts (75.1 and 84.1%), although less pronounced than in their peripheral blood leukocytes (91 and 100%) (Supplementary Figure 6A ). This difference could be due to acquired changes in the methylation pattern in fibroblasts during culturing, as RNA expression analysis for the Xchromosome encoded genes HUWE1 and NAP1L3 confirmed that XCI in the skin fibroblasts was highly skewed, corresponding to the XIR observed in peripheral blood leukocytes. RLIM expression analysis revealed that the mutated allele was not expressed in the majority of cells ( Supplementary Figure 6B ), suggesting that in the carrier females the X-chromosome which carries the RLIM variant is preferentially inactivated.
RLIM locus and variant identification
In four families (C, D, F, and H) the RLIM missense variants were identified by X-chromosome exome sequencing, in two families (A, G) by WES, and in two families (E, I) by WGS. In three families linkage analysis was performed. For Family D the maximum LOD score was 2.0 with the gene locus between Xp11.23 and Xq21.32 [5] . For Family G haplotype analysis using SNP arrays in two affected and five healthy males showed that the affected males share an X-linked region spanning 23.14 Mb, between markers rs4986622 and rs980114, with a maximum LOD score of 1.8. In these families the corresponding X-chromosome regions encompassed the RLIM gene.
All missense variants co-segregated with the phenotype (Fig. 1 ) and except for one variant (Family A, p.(Pro77-Leu)) located in exon 4, they clustered in exon 5 and altered highly conserved amino acids of the RLIM putative basic binding domain (Families B-D) or of the C-terminal catalytic RING-H2 zinc finger (Families E-I) ( Fig. 3A and Supplementary Figure 1 ). Contrary to these diseaseassociated variants, the majority of RLIM missense variants reported in males in, e.g., gnomAD database, which is significantly depeleted of individuals with neurodevelopmental disabilities, are located outside these domains. The variants were predicted to affect function by in silico analysis including PolyPhen-2 and MutationTaster (see Supplementary Table 1 ). Except for the p.(Pro77Leu) substitution, which has been seen in eight heterozygous and two hemizygous individuals in gnomAD database (allele frequency of 5.812 × 10 −5 ), the variants identified in this study were not listed in publicly available databases. Combined the clinical, genetic and in silico data strongly suggested that these variants affect RLIM function.
Pathogenic RLIM variants alter its ubiquitin ligase activity in vitro
The protein regions of RLIM harboring the identified variants have not been functionally characterized, but the homologous regions in the mouse counterpart are highly conserved. In the mouse, the catalytic RING-H2 zinc finger is essential for poly-ubiquitinating its substrate REX1 (also known as ZFP42), leading to REX1 proteasomal degradation. REX1 encodes a transcription factor, a member of the YY1 subfamily of cysteine-histidine (C2H2) zinc finger proteins. REX1 is considered to be a marker for mouse and human embryonic stem cells and is involved in XCI in the mouse [2] . Given the highly skewed XCI in the carrier females with heterozygous RLIM variants, we investigated whether these RLIM variants have an effect on REX1 ubiquitination by performing in vitro ubiquitination assays in HEK293 cells. Constructs encoding either FLAG-RLIM WT or one of the RLIM variants were co-transfected with V5-REX1. V5-REX1 pull-down was performed using anti-V5 antibody coupled beads from nuclear fractions pretreated with the proteasome inhibitor MG132. Subsequent western blot analysis revealed that all RLIM mutants are able to bind REX1. However, there was a clear difference in the ubiquitin ligase activity between WT RLIM and four RLIM variants (Fig. 3B) . Specifically, co-expression of tagged REX1 with the pathogenic RLIM variants p. 
Absence of functional rlim in zebrafish embryos leads to microcephaly not rescued by the human RLIM variants
In addition to in vitro assays performed in cells, we investigated the identified RLIM variants in vivo in the developing zebrafish embryos. Given the microcephaly in affected males, we sought to determine whether the zebrafish homolog of human RLIM, rlim, plays a role during brain development. We asked whether its absence might lead to abnormal head size in our model and, whether the variants identified in our cohort could rescue this phenotype. First, we identified a single rlim gene in zebrafish (Ensembl: ENSDART:00000113567.3) with 66% sequence similarity with human RLIM. We designed a sb-MO against zebrafish rlim and its efficiency was confirmed by RT-PCR ( Supplementary Figure 7) . We injected the sb-MO into oneto-two cell stage zebrafish embryos. MO-injected embryos were stained and measured for head size at 5 dpf. We observed a significant reduction of the head size in rlim morphants compared to controls (p < 0.001, n = 80-90 embryos per condition; experiment replicated three times; Fig. 4) . To test the specificity of the rlim sb-MO, we coinjected the sb-MO along with the human WT RLIM mRNA. Compared to sb-MO alone, the co-injection of MO and WT mRNA led to a complete rescue of the head size phenotype (p < 0.001 sb-MO alone vs. sb-MO and WT mRNA, Fig. 4) suggesting that the effect of the sb-MO was specific to rlim and that the microcephaly was not due to toxicity or off-target effects. To validate our findings, we generated a F0 population of CRISPR mutant rlim embryos by introducing small indels in the zebrafish ortholog of RLIM using CRISPR/Cas9 genome editing approach. We designed and tested several gRNAs targeting rlim. We selected a gRNA that gave 75% of mosaicism in the F0 population as determined by T7 endonuclease I assay followed by Sanger sequencing (see Supplementary Figure 7C) . We scored these mutant embryos for head size defects at 5 dpf and found a significant reduction of the head size compared to sham-injected controls (p < 0.001, n = 35-40 embryos per condition, three independent experiments) (Fig. 4) . The embryos injected with either the gRNA or the Cas9 protein were indistinguishable from controls. These data suggested that rlim is required during early brain development in zebrafish embryos. We determined the pathogenicity of the RLIM variants found in our cohort. We co-injected rlim sb-MO with RLIM mRNAs carrying one of the following variants: p. (Arg599Cys), p.(Arg611Cys) and determined whether the mutant mRNAs rescued the microcephaly phenotype induced by the sb-MO. We observed that all seven mutant RNAs failed to rescue the head size phenotype and were likely acting as loss-of-function alleles (Fig. 4) . To confirm the specificity of our functional assay, we also tested a common variant in RLIM found in the gnomAD database: p. (Asn178Thr) (MAF:0.002, 157 hemizygous individuals). As expected, this variant scored benign in our assay; the p. (Asn178Thr) nonpathogenic polymorphic variant was able to rescue the head size phenotype (p < 0.001 compared to sb-MO alone, Fig. 4 ). Finally, overexpression of the WT or mutant mRNAs alone led to no head size defect, which supported our conclusion that the missense variants more likely act as loss-of-function alleles than having a gain-offunction or dominant negative effect ( Supplementary Figure 8) . Taken together, our in vivo data showed that absence of functional rlim leads to microcephaly and that all seven human RLIM variants present in the families failed to rescue head size and are likely loss-of-function alleles. However despite the results obtained in zebrafish, pathogenicity of the p.(Pro77Leu) variant identified in Family A remains uncertain (see Discussion below).
Discussion
The presented families with RLIM variants indicate that defective RLIM protein function caused a novel syndromic form of XLID in the affected surviving males. These males have a recognizable facial phenotype, ID, behavioral problems starting at puberty, hypogenitalism, gait problems, short stubby thumbs, and pes planus ( Table 1 , Fig. 2 , Supplementary text, Supplementary Table 1 , Supplementary  Figure 4 , Supplementary Videos 1 and 2). Progressive neurological features such as walking problems evolving to spasticity were noted in affected males with and without seizures. Additional neuroimaging, in particular imaging that is more sensitive to subtle white matter abnormalities, such as FLAIR images (MRI) and PET, will clarify how common the white matter changes are, and whether pituitary atrophy or pineal gland cysts are consistent features of the disorder. Identification of further cases at older ages will determine whether progressive neurological symptoms and neurodegenerative disorders such as Alzheimer dementia occur in RLIM-related disorder. Currently, treatment is limited to early intervention, special education, family support and treatment for associated seizure, behavioral, sleep and mental health conditions, as well as recurrence risk counseling.
No particular anti-epileptic medication was found to be consistently more effective in the affected males (Families A, C, D, and F) with seizure disorders, and most affected individuals from Families D and F were seizure free on medication (e.g., Depakin). For mild spasticity, no treatment was given. However, in the severe case (A.II.2) a baclofen pump eased the spasticity. The psychiatric disorders in the adults, e.g., schizophrenia (C.IV:2) and fear/anxiety (D. III.11) were mainly treated with antipsychotic drugs (e.g., Haldol).
Despite the growing number of families with pathogenic variants in RLIM, there is no clear genotype-phenotype correlation appearing. The severely affected boy with the maternally inherited RLIM variant (p.(Pro77Leu)) from Family A fits well into the RLIM clinical spectrum. However, despite the strongly overlapping clinical features with males who carry a pathogenic variant in RLIM and the results obtained in zebrafish, there are several lines of evidence which argue against the pathogenicity of this variant. It was present in only one affected individual, the same variant was identified in two males in gnomAD, the variant did not show a functional effect in the ubiquitination assay and did not cluster with the rest of the RLIM variants. Combined, the pathogenicity of the p.(Pro77Leu) variant identified in Family A remains uncertain until additional similarly affected males with this variant are identified and the mechanism how this variant could cause disease is resolved.
Most non-surviving males and two of three affected fetuses presented with multiple congenital malformations including (relative) microcephaly, CDH with associated LH, urogenital abnormalities, and short terminal phalanges (e.g., stubby thumbs) with or without nail hypoplasia or absent nails. Earlier chromosome studies identified several recurrent deletions in patients with CDH, including, e.g., 1q41-42, 8p23.1, and 15q26. Recently, efforts at identifying other genetic causes using large cohorts of patients with CDH have been made [34, 35] and several critical CDH genes have been identified such as ZFPM2, GATA4, GATA6 [36, 37] and rare variants in other genes, e.g., STAG2 which is implicated in a syndromic form of XLID with microcephaly and a behavioral phenotype [38] [39] [40] . Complex disorders including CDH with associated LH (and pulmonary hypertension) include Donnai-Barrow syndrome (LRP2), CHARGE syndrome (CHD7), Matthew-Wood syndrome (STRA6), Simpson-Golabi-Behmel syndrome (GPC3), Cornelia de Lange syndrome (NIPBL), and autosomal recessive Fryns Syndrome (PIGN) [32] . In the past, there have been speculations on an X-linked form of Fryns syndrome. Fryns syndrome is characterized by diaphragmatic defects (diaphragmatic hernia, eventration, hypoplasia, or agenesis); characteristic facial appearance (coarse facies, ocular hypertelorism, broad and flat nasal bridge, thick nasal tip, long philtrum, low-set and poorly formed ears, tented upper lip, macrostomia, micrognathia); distal digital hypoplasia (nails, terminal phalanges); pulmonary hypoplasia; and associated anomalies (polyhydramnios, cloudy corneas, and/or microphthalmia, orofacial clefting, renal dysplasia/renal cortical cysts, and/or malformations involving the brain, cardiovascular system, gastrointestinal system, genitalia) [41] . Comparison between Fryns syndrome and the syndrome associated with RLIM variants led us to conclude that both syndromes have congenital malformations in common (See Supplementary Figure 2 ) except for the facial features and eye abnormalities.
The heterozygous female carriers have normal cognition and behavior, but can have mild skeletal features. We speculate that this might be related to the presence of cells with an inactivated WT X-chromosome, the proportion of which might vary among different females and vary in different tissues of the heterozygous carrier females. POI is a key feature of the RLIM syndrome similar to various other syndromic or non-syndromic forms of POI, including FMR1 (Xq27.3) pre-mutation, and rare variants in genes affecting the TGF-beta and bone morphogenetic proteins (BMPs) signaling pathway such as BMP15 (Xp11.22) and FOXL2 (3q22) [42] . The RLIM gene and protein are expressed in follicle cells (http://www.proteinatlas.org/ ENSG00000131263-RLIM/tissue) and in these cells the inactive X chromosome is reactivated, which could result in a dominant negative effect or gain-of-function effect of mutant RLIM or in happloinsuffiency. Whether the mutations presented in this study affect human XCI needs further investigation. Notably, RLIM variants in all reported families segregated with highly skewed XCI (>95%) in the carrier females with preferential inactivation of the mutant X-chromosome, whereas none of the noncarrier female relatives displayed highly skewed XCI. Highly skewed XCI could be the result of primary or secondary skewing, which we cannot distinguish from our data. Secondary skewing due to cell selection is more frequently observed in heterozygous females from families with X-linked disorders, and points to a more general protein function. In mouse, RLIM was identified as an important trans-acting activator of XCI, and mutations lead to primary skewed XCI [14] [15] [16] 43] . Primary XCI skewing in humans is very rare. Nevertheless, the involvement of skeletal tissue in Family D, could suggest that the observed XCI is primary, and that RLIM regulates human XCI.
RLIM is an E3 ubiquitin ligase and plays together with other proteins a crucial role within the ubiquitin-proteasome system (UPS), and several ligases and coenzymes within the UPS play an important role in the spatial and temporal control of protein turnover in the nervous system [44] . The UPS regulates the development and maintenance of specialized neuronal structures, and consequently, neuronal transmission. Its dysregulation leads to various movement disturbances, dementia and hypogonadotropic hypogonadism [44, 45] . Thus, it is not surprising that a growing group of ID proteins are directly involved in UPS-mediated protein degradation, such as UBE3A [46] [47], UBE2A [48, 49, 50, 51] , UBE3B [52, 47] , HUWE1 [53, 54, 55] , MID1 [56] [57] [58] [59] , CUL4B [60, [61] [62] [63] , UBR1 [64, 65, 66] , TRIP12 [67] [68] [69] , and RNF216 [45, [70] [71] [72] .
Combining our clinical and genetic results with entries in freely accessible databases (e.g., gnomAD, ExAC, Decipher, ClinVar, dbVar), we hypothesize that most likely total loss-of-RLIM function in males is incompatible with life, as reflected by the RLIM missense variants causing lethality in some affected males from several families. These missense variants affect highly conserved amino acids and all but one lie within the two RLIM protein domains ( Fig. 3A and Supplementary Figure 1) .
Rlim is widely expressed in the mouse during embryogenesis and regulates proteins implicated in cellular and developmental processes, including CLIM [8, 9] , LMO [8] , HDAC2 [73] , TRF1 [18] , SMAD77 [11] , and REX1 [2, 43] through its ubiquitin ligase activity. Strikingly, our in vitro studies examining ubiquitination level of co-expressed REX1, the human counterpart of the well-established RLIM ubiquitin ligase substrate in the mouse, revealed that overexpressed mutant RLIM is able to bind REX1, but all pathogenic variants in the RING-H2 zinc finger of RLIM had highly impaired ubiquitin ligase activity. In contrast mutant RLIM with amino acid changes located outside the RING-H2 zinc finger did not have a major effect on REX1 ubiquitination level. From our clinical data, we observed that variants of the C-terminal RING-H2 zinc finger seem more deleterious than variants located in the RLIM binding region (e.g., severe and lethal affected males in Families E, G, and I).
Although, these studies were performed in vitro and we do not know the consequences of altered ubiquitination of REX1, it is possible that mutant RLIM has an effect on REX1 in vivo. REX1 is expressed in several organs, including the brain, and plays an important role in differentiation, proliferation, and pluripotency. Recent proteomic and network analysis of proteins regulated by REX1 in human embryonic stem cells revealed that it affects several intracellular processes, including translation, regulation of mitochondrial processes, and specific differentiation [74] , which might be affected in the patients with RLIM variants.
RLIM/Rlim regulates various other substrates including its interactor Smad7, an important negative regulator of the TGF-beta signaling pathway [75] . RLIM depletion in mammalian cells reduces SMAD7 ubiquitination, thereby stabilizing SMAD7. The resulting accumulation of SMAD7 inhibits TGF-beta signaling by promoting its proteasomal degradation. Conversely, RLIM/Rlim positively regulates activin and BMP/Smad signaling and controls embryonic stem cell fate and morphogenesis by targeting SMAD7/ Smad7 for degradation, as shown in both mouse embryonic stem cells and zebrafish embryos [11] . In addition, Rlim antagonizes Smad7 during Nodal-dependent and BMPdependent signaling and morphogenetic events in early zebrafish development [11] . Although possible effects of mutant human RLIM on TGF-beta and BMP signaling needs more investigation, in humans failure of TGF-beta signaling leads to digit malformation syndromes [76] . Similarly, disturbances of the BMP signaling pathway, which plays multiple roles in nervous system development and differentiation including proper formation of the forebrain, cause various phenotypes similar to the clinical features present in the families with RLIM missense variants. For example, BMP4 is involved in lung development, plays an essential role in atrioventricular septation of the heart, is important for complete development of the urethra during embryonic development, forms the precursor germ cell formation to seminal vesicle development and is involved in the generation of preadipocytes from mesenchymal stem cells followed by differentiation into adipocytes [77] . Knockdown of BMP4 in chicken leads to lethal CDH and LH [78] . Four RLIM-affected males presented with CHD resembling CHD types described in the 22q11-deletion syndrome. TBX1, which resides in this 22q11 chromosomal region, is very dose sensitive and is involved in the formation of the secondary heart field together with its targets, e.g., SMAD7 [79] , SHH, FGF8 and BMP4 [80] , indicating once again the involvement of subtle (dose) dysregulation of RLIM downstream effectors can have consequences for the expression of the clinical phenotype.
A frequent clinical feature of the affected boys is microcephaly. This prompted us to study the variants identified in the families in vivo using zebrafish embryo as a model. Zebrafish has a single rlim orthologue. Knockdown of rlim in zebrafish using antisense sb-MO or CRISPR/Cas9 genome editing tool caused a statistically significant smaller head size. Co-injection of sb-MO and WT human RLIM completely rescued the phenotype. In contrast, none of the variants identified in the families rescued the small head size of zebrafish morphants, thereby further supporting the deleterious nature of the RLIM variants. These in vivo data have been further confirmed by an independent study in Xenopus where rlim knockdown gives rise to mesenchymal small brains, branchial arch and mesonephros malformations [10] . Comparable clinical features are present in some RLIM-affected (non-surviving) males.
RLIM interacts with several pathways involved in normal brain development (SOX [81] [82] [83] , FGF [84] , SHH [85] , LHX [8] ) and key interactors cause psychiatric disorders. Recently, the transcriptional factor NPAS3 has been identified as a RLIM-interacting protein in neural stem cells [86] . NPAS3 has been associated to psychiatric disorders with several lines of evidence: three nonsynonymous variants in NPAS3 associated with schizophrenia [87] , a balanced chromosome translocation that disrupted NPAS3 [87, 88] , and, population studies have associated common genetic variants of NPAS3 [89] , bipolar disorder [90] , and antipsychotic efficacy [91] . Knockout mice showed behavioral and hippocampal neurogenesis defects consistent with human illness [92] . We speculate that RLIM dysregulation can impair normal NPAS3 function in the adult brain of males with RLIM defects. Furthermore, Npas3 is expressed in early embryonic lung tissue and Npas3-null mice have reduced lung branching morphogenesis but are viable prenatally. Newborns die because of respiratory distress, with decreased Shh, Fgf9, Fgf10, and Bmp4 mRNAs and increased Spry2 expression, consistent with reduced FGF signaling [93] . The ubiquitin ligase activity of RLIM is essential for corepressor dependent transcriptional activation of the LIM-HD transcription factors LHX3 and LHX4 [9] , which are important for pituitary development, e.g., mutations in human LHX3 and LHX4 genes cause combined pituitary hormone deficiency [9] . Furthermore, RLIM acts as a co-regulator of LIM-HD containing transcription factors via the recruitment of the Sin3A/histone deacetylase co-repressor complex. Haploinsufficiency of SIN3A causes a recognizable ID syndrome with a subset of the individuals displaying ASD, seizures, microcephaly and short stature [94] . Also, pathogenic variants in the RLIMinteracting protein YY1, a zinc finger transcription factor, which is implicated in the regulation of XCI [2] in mice, cause a syndromic form of ID with behavioral disturbances, intrauterine growth restriction, and various congenital malformations, through dysregulation of key transcriptional regulators [95] . These findings could hint at RLIM-NPAS3, RLIM-SIN3A, and RLIM-YY1 co-regulatory functions that, when impaired by genetic mutations, lead to clinically overlapping neurodevelopmental disorders.
The detailed phenotype analysis of the families with pathogenic variants, or variant of unknown significance in the case of Family A, affecting RLIM's function showed that mutations in this gene cause a recognizable X-linked syndromic disorder. More work is required to understand the pathophysiology of RLIM-related conditions in the patients. Our current data suggest that a hypomorphic RLIM allele affects the brain and multiple other organs during development with consequences for male offspring. We recommend that RLIM be included in panels for pre-and/or postnatal genetic investigation of undiagnosed diaphragmatic hernia, MCA with genital abnormalities, nail hypoplasia and for (syndromic) ID with behavioral problems in males and nonrandom skewing in heterozygous female carriers.
